Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.

Murphy S, Rosenthal DS, Weinfeld A, Briere J, Faguet GB, Knospe WH, Landaw SA, Laszlo J, Pisciotta AV, Tartaglia AP, et al. Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report. Cancer Treat Rep. 1982 Jul; 66(7):1495-500.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.